ClinicalTrials.gov
ClinicalTrials.gov Menu

Online Self-help for Depressed Patients Awaiting Psychotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01226238
Recruitment Status : Terminated
First Posted : October 22, 2010
Last Update Posted : June 26, 2014
Sponsor:
Information provided by (Responsible Party):
Philipp Klein, University of Luebeck

Brief Summary:
Patients with major depression who are on a waiting list for psychotherapy usually suffer from considerable symptoms. Online self-help is one potential way to alleviate this suffering. The investigators want to study if patients awaiting psychotherapy benefit from online-self help. The investigators therefore randomly assign patients to either online self-help or no intervention and assess their depressive symptoms on a regular basis. The investigators hypothesize that online self-help will be superior to no intervention in alleviating depressive symptoms in depressed patients awaiting psychotherapy.

Condition or disease Intervention/treatment Phase
Major Depressive Disorder Other: Online self-help Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 230 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : October 2010
Actual Primary Completion Date : June 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Online self-help
Provision of online self-help while waiting for psychotherapy
Other: Online self-help
Provision of online self-help
No Intervention: Waiting list alone
Waiting for psychotherapy alone



Primary Outcome Measures :
  1. Depressive Symptomatology [ Time Frame: up to 16 weeks ]

Secondary Outcome Measures :
  1. Depressive Symptomatology [ Time Frame: 6 weeks, up to 10 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Major Depressive Disorder
  • stable medication
  • 18yrs. or older

Exclusion Criteria:

  • current psychotherapy
  • acute suicidality
  • unavailability of internet connection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01226238


Locations
Germany
MVZ Falkenried
Hamburg, Germany
Sponsors and Collaborators
University of Luebeck

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Philipp Klein, Dr. med., University of Luebeck
ClinicalTrials.gov Identifier: NCT01226238     History of Changes
Other Study ID Numbers: Deprexis-HH-HL-WL
First Posted: October 22, 2010    Key Record Dates
Last Update Posted: June 26, 2014
Last Verified: June 2014

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders
Behavioral Symptoms